Summary
Antibiotics versus placebo for acute bacterial conjunctivitis: a Cochrane review
Yu-Yen Chen1-5, Alison Su-Hsun Liu6,7, Ulugbek Nurmatov8, Onno CP van Schayck9, Irene C Kuo2
Affiliation of the authors
1Department of Ophthalmology, Taichung Veterans General Hospital, Taichung, Taiwán. 2Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, Estados Unidos. 3School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwán. 4School of Medicine, Chung Shan Medical University, Taichung, Taiwán. 5Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwán. 6Department of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, Estados Unidos. 7Department of Epidemiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, Estados Unidos. 8Division of Population Medicine, School of Medicine, the National Centre for Population Health and Wellbeing Research, CardiB University, CardiB, Reino Unido. 9Department of Family Medicine, Maastricht University (CAPHRI), Maastricht, Países Bajos.
DOI
Quote
Chen YY, Su-Hsun Liu A, Nurmatov U, van Schayck OCP, Kuo IC. Antibiotics versus placebo for acute bacterial conjunctivitis: a Cochrane review. Emergencias. 2025;37:141-2